SLENDRIN Trademark

Trademark Overview

On Friday, August 20, 2021, a trademark application was filed for SLENDRIN with the United States Patent and Trademark Office. The USPTO has given the SLENDRIN trademark a serial number of 90893395. The federal status of this trademark filing is REGISTERED as of Tuesday, February 28, 2023. This trademark is owned by Sapphire Healthcare, LLC. The SLENDRIN trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements
slendrin

General Information

Serial Number90893395
Word MarkSLENDRIN
Filing DateFriday, August 20, 2021
Status700 - REGISTERED
Status DateTuesday, February 28, 2023
Registration Number6992963
Registration DateTuesday, February 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesNutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code005
First Use Anywhere DateMonday, December 5, 2022
First Use In Commerce DateMonday, December 5, 2022

Trademark Owner History

Party NameSapphire Healthcare, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33131
Party NameSapphire Healthcare, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33131
Party NameSapphire Healthcare, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33131

Trademark Events

Event DateEvent Description
Tuesday, February 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 28, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 24, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 7, 2022USE AMENDMENT FILED
Friday, January 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 7, 2022TEAS STATEMENT OF USE RECEIVED
Monday, October 17, 2022ASSIGNED TO EXAMINER
Thursday, October 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 15, 2022ASSIGNED TO EXAMINER
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 24, 2021NEW APPLICATION ENTERED

Related Keywords

slendrin supplements nutritional